Skip to main content
    K

    KORU Medical Systems, Inc. (KRMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.69
    -0.01 (-0.27%)

    Market Cap: $160.49M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    KORU Medical Systems, Inc. (KRMD) Financials: Revenue, Profit and Cash Flow

    Updated Nov 10, 2026. Financial statements from company filings, amounts in US dollars.

    KORU Medical Systems reported revenue of $41.13M for the fiscal year ended Dec 31, 2025, up 22.2% from the year before. That year, net income was -$2.64M with a net margin of -6.4%, operating cash flow was $462.40K and free cash flow was -$470.11K. The quarter ended Sep 30, 2026 had revenue of $11.57M and net income of $218.10K.

    Revenue and Margins

    The operating margin was -7.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $12.29M, a compound annual rate of 14.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$41.13M+22.2%62.3%-7.2%-6.4%
    Dec 2024$33.65M+18.0%63.4%-19.2%-18.0%
    Dec 2023$28.52M+2.2%58.6%-36.0%-48.2%
    Dec 2022$27.90M+18.8%55.1%-38.6%-31.0%
    Dec 2021$23.49M-2.8%58.6%-29.9%-19.4%
    Dec 2020$24.18M+4.4%61.8%-5.2%-5.0%
    Dec 2019$23.16M+33.5%64.1%2.5%2.4%
    Dec 2018$17.35M+8.6%62.3%6.7%5.2%
    Dec 2017$15.98M+30.0%59.2%9.3%6.8%
    Dec 2016$12.29MN/A61.6%-6.0%-4.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$41.13M$33.65M$28.52M$27.90M$23.49M$24.18M$23.16M$17.35M$15.98M$12.29M
    Cost of revenue$15.52M$12.31M$11.81M$12.53M$9.72M$9.24M$8.31M$6.54M$6.52M$4.72M
    Gross profit$25.60M$21.33M$16.71M$15.37M$13.77M$14.94M$14.85M$10.81M$9.46M$7.57M
    Research and development$4.39M$5.26M$5.74M$4.96M$2.47M$1.30M$740.48K$241.12K$60.70K$237.49K
    Operating income-$2.97M-$6.45M-$10.27M-$10.78M-$7.03M-$1.25M$585.68K$1.16M$1.48M-$736.25K
    Net income-$2.64M-$6.07M-$13.74M-$8.66M-$4.56M-$1.21M$564.35K$910.57K$1.09M-$535.00K
    EBITDA-$1.81M-$5.18M-$8.90M-$10.09M-$5.90M$1.61M$4.34M$2.37M$1.88M-$474.20K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$11.57M$12.05M$11.76M$10.90M$10.40M$10.19M$9.64M$8.84M$8.18M$8.43M$8.20M$7.19M
    Gross profit$7.55M$7.85M$7.03M$6.82M$6.26M$6.48M$6.05M$5.56M$5.19M$5.48M$5.10M$4.33M
    Operating income$187.12K$626.99K-$864.92K-$547.10K-$867.68K-$312.65K-$1.25M-$1.59M-$1.70M-$1.19M-$1.96M-$2.20M
    Net income$218.10K$252.45K-$807.08K-$486.86K-$777.97K-$206.87K-$1.17M-$1.56M-$1.58M-$988.72K-$1.94M-$7.47M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $538.36K by $8.33M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$28.20M$27.22M$28.46M$42.33M$41.29M$39.92M$13.88M$10.55M$9.28M$8.17M
    Current assets$19.99M$19.13M$20.26M$29.80M$37.32M$37.53M$11.88M$9.03M$7.93M$6.78M
    Cash and equivalents$8.87M$9.58M$11.48M$17.41M$25.33M$27.32M$5.87M$3.74M$3.97M$3.31M
    Total liabilities$11.15M$10.40M$8.11M$11.01M$4.79M$3.76M$2.65M$1.58M$1.61M$1.49M
    Short-term debt$538.36K$787.00K$792.20K$877.46K$604.14K$143.94K$142.18KN/AN/AN/A
    Shareholder equity$17.05M$16.81M$20.35M$31.33M$36.50M$36.16M$11.24M$8.96M$7.67M$6.68M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$28.78T$27.96M$28.59M$28.20M$27.10M$25.52M$27.22M$27.22M$27.39M$27.30M$27.50M$28.46M
    Total liabilities$9.39T$9.91M$11.67M$11.15M$10.64M$8.99M$10.87M$10.40M$9.66M$8.60M$8.38M$8.11M
    Cash and equivalents$7.36T$8.29M$8.77M$8.87M$8.46M$8.05M$8.74M$9.58M$8.81M$10.46M$10.82M$11.48M
    Shareholder equity$19.40T$18.05M$16.92M$17.05M$16.46M$16.53M$16.35M$16.81M$17.73M$18.70M$19.12M$20.35M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$462.40K-$319.72K-$4.89M-$5.40M-$4.32M-$743.32K$320.62K$1.48M$899.91K-$331.62K
    Capital expenditures$932.52K$1.30M$814.60K$2.80M$375.23K$1.06M$425.54K$481.17K$218.33K$415.13K
    Free cash flow-$470.11K-$1.62M-$5.71M-$8.21M-$4.69M-$1.80M-$104.92K$998.50K$681.59K-$746.75K
    Dividends paidN/AN/AN/AN/AN/AN/A$184.77KN/AN/AN/A
    Investing cash flow-$949.79K-$1.33M-$814.60K-$2.80M-$366.17K-$1.04M$1.31M-$1.73M-$219.28K-$416.33K
    Financing cash flow-$221.35K-$248.53K-$218.87K$279.49K$2.71M$23.22M$501.30K$14.43K-$19.36K-$140.74K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$882.83K$216.11K$14.66K$1.09M$65.46K-$460.34K-$237.47K$939.62K-$923.95K$11.34K-$346.72K$1.10M
    Capital expenditures$268.22K$577.37K$89.89K$407.78K$52.49K$28.81K$443.44K$43.57K$1.08M$124.28K$133.08K$196.05K
    Free cash flow-$1.15M-$361.25K-$75.22K$686.97K$12.97K-$489.15K-$680.90K$896.05K-$2.01M-$112.95K-$479.80K$900.75K
    Last 12 quarters

    Frequently Asked Questions About KRMD

    What is KORU Medical Systems' annual revenue?

    KORU Medical Systems reported revenue of $41.13M for the fiscal year ended Dec 31, 2025.

    How fast is KORU Medical Systems' revenue growing?

    Revenue was up 22.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 13.8%.

    Is KORU Medical Systems profitable?

    No. KORU Medical Systems reported net income of -$2.64M for the fiscal year ended Dec 31, 2025, with a net margin of -6.4%.

    How much free cash flow does KRMD generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $462.40K minus capital expenditures of $932.52K produced free cash flow of -$470.11K.

    How much debt does KORU Medical Systems have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $538.36K and cash and equivalents of $8.87M.